Efficient transmicrocatheter delivery of functional fibroblasts with a bioengineered collagen gel-platinum microcoil complex: Toward the development of endovascular cell therapy for cerebral aneurysms

American Journal of Neuroradiology

Volumn 28, Issue 8, 2007, Pages 1586-1593

  Abruzzo, Tod ^a,c   Tun, T ^b   Sambanis, A ^b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Georgia Institute of Technology   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CELL DNA; COLLAGEN GEL; GLUTARALDEHYDE; PLATINUM;

ARTICLE; BRAIN ARTERY ANEURYSM; CATHETERIZATION; CELL CULTURE; CELL DEATH; CELL MIGRATION; CELL THERAPY; CELL VIABILITY; COCULTURE; COIL EMBOLIZATION; CROSS LINKING; CULTURE MEDIUM; DEVICE; ENDOVASCULAR CELL THERAPY; FIBROBLAST; HUMAN; HUMAN CELL; MICROCOIL EMBOLIZATION; NEWBORN; PARTICULATE MATTER;

BIOMEDICAL ENGINEERING; CATHETERIZATION; CELL DEATH; CELL MOVEMENT; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; COLLAGEN; COLORING AGENTS; CROSS-LINKING REAGENTS; DNA; FIBROBLASTS; GELS; GLUTARAL; HUMANS; INTRACRANIAL ANEURYSM; PLATINUM; TETRAZOLIUM SALTS; THIAZOLES;

EID: 34648843090     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A0593     Document Type: Article

References (47)

1. Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267-74
2. Johnston SC, Higashida RT, Barrow DL, et al. Recommendations for the endovascular treatment of intracranial aneurysms: a statement for healthcare professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology. Stroke 2000;33:2536-44
3. Raymond J, Guilbert F, Weill A, et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke 2003;34:1398-403
4. Byrne J, Sohn MJ, Molyneux AJ, et al. Five-year experience in using coil embolization for ruptured intracranial aneurysms: outcomes and incidence of late rebleeding. J Neurosurg 1999;90:656-63
5. Cognard C, Weill A, Spelle L, et al. Long-term angiographic follow-up of 169 intracranial berry aneurysms occluded with detachable coils. Radiology 1999;212:348-56
6. Dawson RC, Krisht AF, Barrow DL, et al. Treatment of experimental aneurysms using collagen-coated microcoils. Neurosurgery 1995;36:133-39; discussion 139-40
7. Dawson RC III, Shengelaia GG, Krisht AF, et al. Histologic effects of collagen-filled interlocking detachable coils in the ablation of experimental aneurysms in swine. AJNR Am J Neuroradiol 1996;17:853-58
8. Murayama Y, Suzuki Y, Vinuela F, et al. Development of a biologically active Guglielmi detachable coil for the treatment of cerebral aneurysms. Part I: in vitro study. AJNR Am J Neuroradiol 1999;20:1986-91
9. Murayama Y, Vinuela F, Suzuki Y, et al. Ion implantation and protein coating of detachable coils for endovascular treatment of cerebral aneurysms: concepts and preliminary results in swine models. Neurosurgery 1997;40:1233-43; discussion 1243-44
10. Szikora I, Wakhloo AK, Guterman LR, et al. Initial experience with collagen-filled Guglielmi detachable coils for endovascular treatment of experimental aneurysms. AJNR Am J Neuroradiol 1997;18:667-72
11. Raymond J, Desfaits AC, Roy D. Fibrinogen and vascular smooth muscle cell grafts promote healing of experimental aneurysms treated by embolization. Stroke 1999;30:1657-64
12. Kallmes DF, Williams AD, Cloft HJ, et al. Platinum coil-mediated implantation of growth factor-secreting endovascular tissue grafts: an in vivo study. Radiology 1998;207:519-23
13. Kallmes DF, Borland MK, Cloft HJ, et al. In vitro proliferation and adhesion of basic fibroblast growth factor-producing fibroblasts on platinum coils. Radiology 1998;206:237-43
14. Marx WE, Cloft HJ, Helm GA, et al. Endovascular treatment of experimental aneurysms by use of biologically modified embolic devices: coil-mediated intraaneurysmal delivery of fibroblast tissue allografts. AJNR Am J Neuroradiol 2001;22:323-33
15. Nishiyama T, Tominaga N, Nakajima K, et al. Quantitative evaluation of the factors affecting the process of fibroblast-mediated collagen gel contraction by separating the process into three phases. Coll Relat Res 1988;8:259-73
16. Berglund JD, Mohseni MM, Nerem RM, et al. A biological hybrid model for collagen-based tissue engineered vascular constructs. Biomaterials 2003;24:1241-54
17. Kuroyanagi M, Shimamura E, Kim M, et al. Effects of L-ascorbic acid on lysyl oxidase in the formation of collagen cross-links. Biosci Biotechnol Biochem 2002;66:2077-82
18. Abruzzo T, Cloft HJ, Shengelaia GG, et al. In vitro effects of transcatheter injection on structure, cell viability, and cell metabolism in fibroblast-impregnated alginate microspheres. Radiology 2001;220:428-35
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63
20. Arndt-Jovin DJ, Jovin TM. Analysis and sorting of living cells according to deoxyribonucleic acid content. J Histochem Cytochem 1977;25:585-89
21. Nishi C, Nakajima N, Ikada Y. In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification. J Biomed Mater Res 1995;29:829-34
22. Sun HW, Feigal RJ, Messer HH. Cytotoxicity of glutaraldehyde and formaldehyde in relation to time of exposure and concentration. Pediatr Dent 1990;12:303-07
23. Slesinski RS, Hengler WC, Guzzie PJ, et al. Mutagenicity evaluation of glutaraldehyde in a battery of in vitro bacterial and mammalian test systems. Food Chem Toxicol 1983;21:621-29
24. Albini A, Morini M, D'Agostini F, et al. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine. Cancer Res 2001;61:8171-78
25. Reed MJ, Corsa AC, Kudravi SA, et al. A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells. J Cell Biochem 2000;77:116-26
26. Pilcher BK, Dumin JA, Sudbeck BD, et al. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 1997;137:1445-57
27. Raymond J, Metcalfe A, Desfaits AC, et al. Alginate for endovascular treatment of aneurysms and local growth factor delivery. AJNR Am J Neuroradiol 2003;24:1214-21
28. Cloft HJ, Kallmes DF. Aneurysm packing with HydroCoil Embolic System versus platinum coils: initial clinical experience. AJNR Am J Neuroradiol 2004;25:60-62
29. Wang DA, Williams CG, Li Q, et al. Synthesis and characterization of a novel degradable phosphate-containing hydrogel. Biomaterials 2003;24:3969-80
30. Wallace DG, Rosenblatt J. Collagen gel systems for sustained delivery and tissue engineering. Adv Drug Deliv Rev 2003;55:1631-49
31. Kemp PD. Tissue engineering and cell-populated collagen matrices. Methods Mol Biol 2000;139:287-93
32. Chevallay B, Herbage D. Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy. Med Biol Eng Comput 2000;38:211-18
33. Yoshino Y, Niimi Y, Song JK, et al. Endovascular treatment of intracranial aneurysms: comparative evaluation in a terminal bifurcation aneurysm model in dogs. J Neurosurg 2004;101:996-1003
34. Ahsan T, Nerem RM. Bioengineered tissues: the science, the technology, and the industry. Orthod Craniofac Res 2005;8:134-40
35. Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11:321-24
36. Rippon HJ, Bishop AE. Embryonic stem cells. Cell Prolif 2004;37:23-34
37. Wendt JR, Ulich T, Rao PN. Long-term survival of human skin allografts in patients with immunosuppression. Plast Reconstr Surg 2004;113:1347-54
38. Johnson DL, Rose ML, Yacoub MH. Immunogenicity of human heart valve endothelial cells and fibroblasts. Transplant Proc 1997;29:984-85
39. Morimoto N, Saso Y, Tomihata K, et al. Viability and function of autologous and allogeneic fibroblasts seeded in dermal substitutes after implantation. J Surg Res 2005;125:56-67
40. Sambanis A. Encapsulated islets in diabetes treatment. Diabetes Technol Ther 2003;5:665-68
41. Cellular and gene therapy. United States Food and Drug Administration, Center for Biologies Evaluation and Research. Available at: http://www.fda.gov/Cber/gene.htm. Accessed July 27, 2006
42. Snider S. FDA talk paper. FDA approves temporary skin substitute for burn patients. March 19, 1997. United States Food and Drug Administration. Available at: http://www.fda.gov/bbs/topics/ANSWERS/ ANS00791.html. Accessed July 27, 2006
43. FDA talk paper. FDA approves new product for diabetic foot ulcers. June 20, 2000. United States Food and Drug Administration. Available at http://www.fda.gov/bbs/topics/ANSWERS/ANS01022.html. Accessed August 1, 2006
44. Clinical trials. United States National Institute of Health Clinical Trials. Available at: http://www.clinicaltrials.gov/ct/show/ NCT00221130?order=2. Accessed July 27, 2006
45. Clinical trials. United States National Institute of Health Clinical Trials. Available at: http://www.clinicaltrials.gov/ct/show/ NCT00250302?order=1. Accessed July 27, 2006
46. Clinical trials. United States National Institute of Health Clinical Trials. Available at: http://www.clinicaltrials.gov/ct/show/ NCT00300053?order=4. Accessed July 27, 2006
47. Stover NP, Bakay RA, Subramanian T, et al. Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease. Arch Neurol 2005;62:1833-37